Biological drug and drug delivery-mediated immunotherapy.
Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z, He W.
Acta Pharm Sin B. 2021 Apr;11(4):941-960. doi: 10.1016/j.apsb.2020.12.018. Epub 2020 Dec 31.
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, et al.
Blood. 1995 Apr 15;85(8):2025-37.
Association of CDKN2A/B mutations, PD-1, and PD-L1 with the risk of acute lymphoblastic leukemia in children.
Ruan Y, Xie L, Zou A.
J Cancer Res Clin Oncol. 2023 Sep;149(12):10841-10850. doi: 10.1007/s00432-023-04974-x. Epub 2023 Jun 14.
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets.
Kumar AR, Devan AR, Nair B, Vinod BS, Nath LR.
Mol Biol Rep. 2021 Dec;48(12):8075-8095. doi: 10.1007/s11033-021-06752-9. Epub 2021 Oct 20.
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells.
Liu L, Chen J, Bae J, Li H, Sun Z, Moore C, Hsu E, Han C, Qiao J, Fu YX.
Nat Biomed Eng. 2021 Nov;5(11):1261-1273. doi: 10.1038/s41551-021-00800-2. Epub 2021 Nov 1.
MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M, Felsher DW.
Science. 2016 Apr 8;352(6282):227-31. doi: 10.1126/science.aac9935. Epub 2016 Mar 10.
Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis.
Yin J, Yin Q, Liang B, Mi R, Ai H, Chen L, Wei X.
Naunyn Schmiedebergs Arch Pharmacol. 2020 Feb;393(2):273-286. doi: 10.1007/s00210-019-01778-0. Epub 2019 Dec 14.
Programmed Death Ligand-1 is Frequently Expressed in Primary Acute Myeloid Leukemia and B-Acute Lymphoblastic Leukemia.
Hamdan SO, Sughayer M, Khader M, Tbakhi A, Khudirat S, Hejazi A, AlRyalat S, Bustami N, Aladily TN.
Clin Lab. 2022 Apr 1;68(4). doi: 10.7754/Clin.Lab.2021.210701.
Leukemia Cutis: An Unusual Presentation of Acute Lymphoblastic Leukemia in a Child.
Jiang X, Wang W, Zhang M.
Indian J Dermatol. 2015 Nov-Dec;60(6):636. doi: 10.4103/0019-5154.169153.
Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia.
Tracy SI, Venkatesh H, Hekim C, Heltemes-Harris LM, Knutson TP, Bachanova V, Farrar MA.
Blood. 2022 Jul 28;140(4):335-348. doi: 10.1182/blood.2021015341.
